AstraZeneca vaccine followed by Pfizer dose is 'highly safe, effective': Study
The Combivacs study, run by Spain's state-backed Carlos III Health Institute, found the presence of IgG antibodies in the bloodstream was between 30 and 40 times higher in people who got the follow-up Pfizer shot than in a control group who only received one AstraZeneca dose.
Pfizer, Moderna vaccines effective against Indian variants: Study
The lab-based study was carried out by the NYU Grossman School of Medicine and NYU Langone Center and is considered preliminary because it has not yet been published in a peer-reviewed journal.
COVID-19 vaccine for children: Is it safe for my child to take the jab?
Is COVID-19 vaccine safe for children? Recently released data from Pfizer-BioNTech shows the COVID-19 vaccine works well in the age group of 12 to 15 years.
Should my child get coronavirus vaccine? 7 questions answered by an expert
US FDA has expanded emergency use authorization of the Pfizer-BioNTech Covid-19 vaccine to include adolescents 12 to 15 years of age
Delayed second Pfizer Covid-19 shot produces more antibodies: Study
Study looked at 175 people aged between 80 and 99; Pfizer clinical trial had three-week gap between doses
Pfizer Ltd - 500680 - Board to consider FY21 results & Dividend on May 26, 2021
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 26, 2021, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2021 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2021.Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders", the Trading Window of the Company was closed from March 31, 2021 (close of business) till 48 hours after the results are made public on May 26, 2021. Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting For The Audited Financial Results For The Financial Year Ended March 31, 2021.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, May 26, 2021, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2021 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2021. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Wednesday, March 31, 2021 (close of business) till 48 hours after the results are made public on May 26, 2021. We request you to kindly take the same on record.
Mixing AstraZeneca and Pfizer shots triggers more fatigue, headaches: Study
About 10% of participants who got mixed doses reported severe fatigue, for instance, compared with about 3% for those inoculated with a single type of vaccine
Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19
World Health Organization classified the B1617 SARS-CoV-2 variant, which was first detected in India, as a variant of concern.USFDA okays Pfizer's Covid-19 vaccine for children in 12-15 age group
Moderna is also undertaking vaccine trials on a similar age group